Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.

Scientists have discovered a new CRISPR mechanism with precise activity, expanding the potential applications of the existing ...

Researchers at Utah State University revealed new details about CRISPR immune system defenses, such as Cas12a3 systems, that ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Researchers uncovered a previously unknown CRISPR immune response in bacteria that targets transfer RNAs. The newly ...

Bayer has opened a new legal front in the long-running battles over COVID-19 vaccine technology, suing several major ...

One of the most well-studied cellular responses is how they react during times of stress, such as when the temperature gets ...

This is a summary of: Liu. H. et al. Viral RNA blocks circularization to evade host codon usage control. Nature https://doi.org/10.1038/s41586-025-09809-y (2025).

Pharmaceutical company Bayer has initiated lawsuits against several major COVID-19 vaccine manufacturers, including Pfizer, BioNTech, and Moderna, alleging unauthorized use of its messenger RNA (mRNA) ...

Genotoxic drugs, the focus of this new study, are commonly used to treat bowel cancer by killing cancer cells through damage ...

Bayer has filed lawsuits in U.S. federal courts seeking a share of the revenue generated from COVID-19 vaccines sold by ...